Ciulla Thomas 4
4 · Clearside Biomedical, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Ciulla Thomas
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-01+40,000→ 40,000 totalExercise: $5.04Exp: 2028-10-24→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]On October 24, 2018, the reporting person was granted an option to purchase 40,000 that vests in full based on the satisfaction of certain performance criteria. The performance criteria were met on March 1, 2021, resulting in the vesting of the option full.